Lee H. Goldstein

Technion – Israel Institute of Technology — Israel

Medicine · Health Sciences

19h-index1.7kcitations56works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(10), Complementary and Alternative Medicine Studies(10), Atrial Fibrillation Management and Outcomes(7), Venous Thromboembolism Diagnosis and Management(7), Pharmacology and Obesity Treatment(5)

Publications56 total

The level is in the details: Why differences between direct‐acting oral anticoagulants should be considered in the treatment of patients with epilepsy
Epilepsia·2024· 1 citedOpen Access
The Influence of High Body Mass Index (BMI > 35 kg/m2) on Apixaban Plasma Concentration in Patients with Atrial Fibrillation
American Journal of Cardiovascular Drugs·2024Open Access
Effectiveness and Safety of Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients With Extreme Obesity
The American Journal of Cardiology·2023· 4 cited
Effectiveness of Molnupiravir in High-Risk Patients: A Propensity Score Matched Analysis
Clinical Infectious Diseases·2022· 59 citedOpen Access
Reply to Chen et al, Uchikoba et al, Siberry et al, and Vuorio et al
Clinical Infectious Diseases·2022· 2 cited
Reply to Pesko et al
Clinical Infectious Diseases·2022· 1 cited
The influence of extremely high body weight (BMI > 35kg/ m2) on apixaban plasma concentration in patients with atrial fibrillation
Research Square (Research Square)·2022Open Access
Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients
Clinical Infectious Diseases·2022· 530 citedOpen Access
First case of imported <i>Capillaria philippinensis</i> in Israel
Journal of Travel Medicine·2021· 3 cited
Increasing adverse drug reaction reporting—How can we do better?
PLoS ONE·2020· 38 citedOpen Access
Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
PLoS ONE·2020· 6 citedOpen Access
Does infection prolong the QT interval?
Internal Medicine Journal·2020· 2 cited
Pharmacokinetics of Anti-Rheumatic Drugs in a Geriatric Patient
2020
Perioperative Risks of Dietary and Herbal Supplements
World Journal of Surgery·2016· 33 cited
Adverse events associated with interactions with dietary and herbal supplements among inpatients
British Journal of Clinical Pharmacology·2016· 71 citedOpen Access
Potential drug interactions with dietary and herbal supplements during hospitalization
Internal and Emergency Medicine·2016· 23 cited
Mind the gap: Disclosure of dietary supplement use to hospital and family physicians
Patient Education and Counseling·2016· 28 cited
Measurement of betamethasone concentration in maternal serum treated for fetal lung maturity; Is it feasible?
Reproductive Biology and Endocrinology·2016· 6 citedOpen Access
Interactions between dietary supplements in hospitalized patients
Internal and Emergency Medicine·2016· 18 cited
Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals
Cancer·2015· 145 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Walid Saliba(17), Mazen Elias(16), Matitiahu Berkovitch(15), Eran Ben‐Arye(8), Elad Schiff(8), Samuel Attias(7), Eran Kozer(6), Ilana Levy(5), Ronza Najjar‐Debbiny(4), Naomi Gronich(4), Regina Weber(4), Johad Khoury(4), Rony Braunstein(3), Maya Berlin(3), Orna Nitzan(3), Adina Bar-Haim(3), Ibrahim Abu‐Kishk(3), Maisam Amar(2), Nili Stein(2), Gideon Koren(2)